Novel mucosal adjuvant, mastoparan-7, improves cocaine vaccine efficacy

dc.contributor.author

St John, Ashley L

dc.contributor.author

Choi, Hae Woong

dc.contributor.author

Walker, Q David

dc.contributor.author

Blough, Bruce

dc.contributor.author

Kuhn, Cynthia M

dc.contributor.author

Abraham, Soman N

dc.contributor.author

Staats, Herman F

dc.date.accessioned

2020-02-06T13:53:02Z

dc.date.available

2020-02-06T13:53:02Z

dc.date.issued

2020-12

dc.date.updated

2020-02-06T13:53:01Z

dc.identifier.issn

2059-0105

dc.identifier.uri

https://hdl.handle.net/10161/20060

dc.language

en

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

npj Vaccines

dc.relation.isversionof

10.1038/s41541-020-0161-1

dc.title

Novel mucosal adjuvant, mastoparan-7, improves cocaine vaccine efficacy

dc.type

Journal article

duke.contributor.orcid

St John, Ashley L|0000-0001-5098-1044

duke.contributor.orcid

Staats, Herman F|0000-0003-1039-1087

pubs.issue

1

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Duke Human Vaccine Institute

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Immunology

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Pathology

pubs.organisational-group

Clinical Science Departments

pubs.publication-status

Published online

pubs.volume

5

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
John_et_al-2020-npj_Vaccines.pdf
Size:
2.52 MB
Format:
Adobe Portable Document Format
Description:
Published version